Astrazeneca's PR battle with its Covid-19 vaccine is intensifying. AZD1222 had already faced questions about its efficacy, and now safety is under the spotlight – with the latest scare coming today from Denmark, which has suspended use of the jab as concerns about blood clots mount.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,